|
 |
|
|||||||
|
|||||||||
Diabetes 52:2701-2719, 2003
© 2003 by the American Diabetes Association, Inc.
Discovery of Gene Networks Regulating Cytokine-Induced Dysfunction and Apoptosis in Insulin-Producing INS-1 Cells
1 Laboratory of Experimental Medicine, Université Libre de Bruxelles, Brussels, Belgium
2 Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Denmark
Locally released cytokines contribute to ß-cell dysfunction and apoptosis in type 1 diabetes. In vitro exposure of insulin-producing INS-1E cells to the cytokines interleukin (IL)-1ß + interferon (IFN)-
leads to a significant increase in apoptosis. To characterize the genetic networks implicated in ß-cell dysfunction and apoptosis and its dependence on nitric oxide (NO) production, we performed a time-course microarray analysis of cytokine-induced genes in insulin-producing INS-1E cells. INS-1E cells were exposed in duplicate to IL-1ß + IFN- for six different time points (1, 2, 4, 8, 12, and 24 h) with or without the inducible NO synthase (iNOS) blocker NG-monomethyl-L-arginine (NMA). The microarray analysis identified 698 genes as cytokine modified (
2.5-fold change compared with control) in at least one time point. Based on their temporal pattern of variation, the cytokine-regulated genes were classified into 15 clusters by the k-means method. These genes were further classified into 14 different groups according to their putative function. Changes in the expression of genes related to metabolism, signal transduction, and transcription factors at all time points studied indicate ß-cell attempts to adapt to the effects of continuous cytokine exposure. Notably, several apoptosis-related genes were modified at early time points (2–4 h) preceding iNOS expression. On the other hand, 46% of the genes modified by cytokines after 8–24 h were NO dependent, indicating the important role of this radical for the late effects of cytokines. The present results increase by more than twofold the number of known cytokine-modified genes in insulin-producing cells and yield comprehensive information on the role of NO for these modifications in gene expression. These data provide novel and detailed insights into the gene networks activated in ß-cells facing a prolonged immune assault.
Address correspondence reprint requests to Décio L. Eizirik, Laboratory of Experimental Medicine CP 618, Université Libre de Bruxelles, Route de Lennik, 808, B-1070, Brussels, Belgium. E-mail: deizirik{at}ulb.ac.be
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Ribaux, J. A. Ehses, N. Lin-Marq, F. Carrozzino, M. Boni-Schnetzler, E. Hammar, J.-C. Irminger, M. Y. Donath, and P. A. Halban Induction of CXCL1 by Extracellular Matrix and Autocrine Enhancement by Interleukin-1 in Rat Pancreatic {beta}-Cells Endocrinology, November 1, 2007; 148(11): 5582 - 5590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kiely, N. H McClenaghan, P. R Flatt, and P. Newsholme Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic {beta}-cell line J. Endocrinol., October 1, 2007; 195(1): 113 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pirot, F. Ortis, M. Cnop, Y. Ma, L. M. Hendershot, D. L. Eizirik, and A. K. Cardozo Transcriptional Regulation of the Endoplasmic Reticulum Stress Gene Chop in Pancreatic Insulin-Producing Cells Diabetes, April 1, 2007; 56(4): 1069 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ortis, A. K. Cardozo, D. Crispim, J. Storling, T. Mandrup-Poulsen, and D. L. Eizirik Cytokine-Induced Proapoptotic Gene Expression in Insulin-Producing Cells Is Related to Rapid, Sustained, and Nonoscillatory Nuclear Factor-{kappa}B Activation Mol. Endocrinol., August 1, 2006; 20(8): 1867 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Luco, M. A. Maestro, N. del Pozo, W. M. Philbrick, P. P. de la Ossa, and J. Ferrer A Conditional Model Reveals That Induction of Hepatocyte Nuclear Factor-1{alpha} in Hnf1{alpha}-Null Mutant {beta}-Cells Can Activate Silenced Genes Postnatally, Whereas Overexpression Is Deleterious. Diabetes, August 1, 2006; 55(8): 2202 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I. Rachek, N. P. Thornley, V. I. Grishko, S. P. LeDoux, and G. L. Wilson Protection of INS-1 Cells From Free Fatty Acid-Induced Apoptosis by Targeting hOGG1 to Mitochondria. Diabetes, April 1, 2006; 55(4): 1022 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cnop, N. Welsh, J.-C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik Mechanisms of Pancreatic {beta}-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities Diabetes, December 1, 2005; 54(suppl_2): S97 - S107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Gysemans, L. Ladriere, H. Callewaert, J. Rasschaert, D. Flamez, D. E. Levy, P. Matthys, D. L. Eizirik, and C. Mathieu Disruption of the {gamma}-Interferon Signaling Pathway at the Level of Signal Transducer and Activator of Transcription-1 Prevents Immune Destruction of {beta}-cells Diabetes, August 1, 2005; 54(8): 2396 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Mathews, W. L. Suarez-Pinzon, J. J. Baust, K. Strynadka, E. H. Leiter, and A. Rabinovitch Mechanisms Underlying Resistance of Pancreatic Islets from ALR/Lt Mice to Cytokine-Induced Destruction J. Immunol., July 15, 2005; 175(2): 1248 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sparre, M. R. Larsen, P. E. Heding, A. E. Karlsen, O. N. Jensen, and F. Pociot Unraveling the Pathogenesis of Type 1 Diabetes with Proteomics: Present And Future Directions Mol. Cell. Proteomics, April 1, 2005; 4(4): 441 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Gysemans, A. K. Cardozo, H. Callewaert, A. Giulietti, L. Hulshagen, R. Bouillon, D. L. Eizirik, and C. Mathieu 1,25-Dihydroxyvitamin D3 Modulates Expression of Chemokines and Cytokines in Pancreatic Islets: Implications for Prevention of Diabetes in Nonobese Diabetic Mice Endocrinology, April 1, 2005; 146(4): 1956 - 1964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Cardozo, F. Ortis, J. Storling, Y.-M. Feng, J. Rasschaert, M. Tonnesen, F. Van Eylen, T. Mandrup-Poulsen, A. Herchuelz, and D. L. Eizirik Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca2+, Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic {beta}-Cells Diabetes, February 1, 2005; 54(2): 452 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Smink, E. M. Helton, B. C. Healy, C. C. Cavnor, A. C. Lam, D. Flamez, O. S. Burren, Y. Wang, G. E. Dolman, D. B. Burdick, et al. T1DBase, a community web-based resource for type 1 diabetes research Nucleic Acids Res., January 1, 2005; 33(suppl_1): D544 - D549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kharroubi, L. Ladriere, A. K. Cardozo, Z. Dogusan, M. Cnop, and D. L. Eizirik Free Fatty Acids and Cytokines Induce Pancreatic {beta}-Cell Apoptosis by Different Mechanisms: Role of Nuclear Factor-{kappa}B and Endoplasmic Reticulum Stress Endocrinology, November 1, 2004; 145(11): 5087 - 5096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maffei, Z. Liu, P. Witkowski, F. Moschella, G. D. Pozzo, E. Liu, K. Herold, R. J. Winchester, M. A. Hardy, and P. E. Harris Identification of Tissue-Restricted Transcripts in Human Islets Endocrinology, October 1, 2004; 145(10): 4513 - 4521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ohara-Imaizumi, A. K. Cardozo, T. Kikuta, D. L. Eizirik, and S. Nagamatsu The Cytokine Interleukin-1{beta} Reduces the Docking and Fusion of Insulin Granules in Pancreatic {beta}-Cells, Preferentially Decreasing the First Phase of Exocytosis J. Biol. Chem., October 1, 2004; 279(40): 41271 - 41274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bain, J. C. Schisler, K. Takeuchi, C. B. Newgard, and T. C. Becker An Adenovirus Vector for Efficient RNA Interference-Mediated Suppression of Target Genes in Insulinoma Cells and Pancreatic Islets of Langerhans Diabetes, September 1, 2004; 53(9): 2190 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Hartman, D. Lu, M.-L. Kim, G. J. Kociba, T. Shukri, J. Buteau, X. Wang, W. L. Frankel, D. Guttridge, M. Prentki, et al. Role for Activating Transcription Factor 3 in Stress-Induced {beta}-Cell Apoptosis Mol. Cell. Biol., July 1, 2004; 24(13): 5721 - 5732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Darville, S. Terryn, and D. L. Eizirik An Octamer Motif Is Required for Activation of the Inducible Nitric Oxide Synthase Promoter in Pancreatic {beta}-Cells Endocrinology, March 1, 2004; 145(3): 1130 - 1136. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |